SCHEMBL6851185

SCHEMBL6851185

NC(=O)c1ccc2cc3ccccc3n2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA7 P36544 1/20 0.43
CHRNA4 P43681 1/20 0.43
HTR3A P46098 1/20 0.43
PARP1 P09874 2/20 0.41
PLA2G10 O15496 2/20 0.40
ROCK2 O75116 1/20 0.40
PIM1 P11309 1/20 0.40
PIM3 Q86V86 1/20 0.40
PLAU P00749 1/20 0.39
LCK P06239 1/20 0.39
FGFR1 P11362 1/20 0.38
HSD17B10 Q99714 2/20 0.38
POLB P06746 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28531553 0.87 CHRNA7 (0.51) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL366724 0.84 CHRNA7 (0.43) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL6851190 0.76 BAZ2B (0.45) PARP1ROCK2PIM1PIM3PLAU
SCHEMBL365476 0.76 SCN9A (0.46) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL29994562 0.71 FYN (0.41) PARP1FGFR1
SCHEMBL29462782 0.69 CES2 (0.68) PARP1PLAULCKHSD17B10POLB
SCHEMBL546633 0.69 CES2 (0.68) PARP1PLAULCKHSD17B10POLB
SCHEMBL4499694 0.69 KMT2A (0.35) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL26903783 0.69 CES2 (0.68) PARP1PLAULCKHSD17B10POLB
SCHEMBL2830160 0.68 PLA2G10 (0.54) PLA2G10ROCK2PIM1PIM3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968339-A1 MK2 INHIBITORS AND USES THEREOF Celgene Avilomics Research, Inc. (US) 2016-01-20 EP disclosed
WO-2014149164-A1 MK2 INHIBITORS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2014-09-25 WO disclosed
EP-1476449-A1 FUSED BICYCLIC-N-BRIDGED-HETEROAROMATIC CARBOXAMIDES FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-11-17 EP disclosed
WO-2003070732-A1 FUSED BICYCLIC-N-BRIDGED-HETEROAROMATIC CARBOXAMIDES FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2003-08-28 WO disclosed